News & Events
- Showing 25–48 of 56 items
ZeptoMetrix® is committed to women’s health. Two new vaginal molecular QC controls, NATVPOS-6C Vaginal Positive Control and NATVNEG-6C Vaginal Negative Control, for in vitro diagnostic use are now available.
ZeptoMetrix launches NEW NATtrol Joint Infection Panel - NATJIP-BIO
Performance verification is a critical component of implementing a diagnostic test in a clinical lab and can be time consuming and costly A verification protocol and organism panel were developed in collaboration with ZeptoMetrix ® to verify all analyte detections for the BioFire ® Joint Infection.
Did you miss our free webinar? Watch the recording now Webinar: Best Practices for Maintaining Quality in Molecular Diagnostic Testing.Learn about considerations for implementing a quality management system for your laboratory.
Did you miss our free webinar? Watch the recording now
Looking ahead in the clinical lab: What’s next after COVID-19?
Serology testing demonstrates that antibodies to SARS-CoV-2 S1-RBD correlate with neutralization of virus infection of Vero E6 cells
Microneutralization end point–dilution assays were performed at ZeptoMetrix. SARS-CoV-2 virus, isolate USA-WA1/2020, NR-52281 (CDC and BEI Resources, National Institute of Allergy and Infectious Diseases, NIH) was used for microneutralization end point–dilution assays.
New ZeptoMetrix® NATtrol™ SARS-CoV-2 Omicron Control Now Available
ZeptoMetrix® new SARS-CoV-2 Lineage B.1.1.529; Omicron Variant CF (Heat Inactivated)is available for immediate Research and Assay Development.
ZeptoMetrix® to release new Non-Infectious SARS-CoV-2 Omicron External Run Control - NATCOV2(OMC)-ERC. Order today!
Development of a Laboratory Verification Protocol for Qualitative and Semi-Quantitative Detections in a Multiplex Syndromic Pneumonia Panel
Reduce Errors and Increase Confidence in Testing with Quality Controls - The Science of Real Life
ZeptoMetrix® launches the SARS-CoV-2 Omicron Control. Now available for pre-order.
ZeptoMetrix® Launches New Ready-to-Use SARS-CoV-2 Delta Variant Molecular Quality Controls.
Rheonix utilizes ZeptoMetrix reagents to advance rapid diagnostic COVID-19 testing.
This podcast series highlights career insights from pharmaceuticals and health science experts.
ZeptoMetrix® supports NovaSterilis in achieving EUA for the Nova2020™ system in decontaminating select N95 respirators.
ZeptoMetrix® to release new Non-Infectious Gastrointestinal Verification Panel NATGIP-QIA
FDA suggests ZeptoMetrix® test materials for SARS-CoV-2 assay validation.
ZeptoMetrix® New SARS-CoV-2 Positive Control-NATSARS(COV2)-ERC and accompanying Negative Control- NATSARS(COV2)-NEG are now available.
ZeptoMetrix® and the University of Buffalo are leveraging resources to develop new quality control products for infectious disease diagnostics.
ZeptoMetrix® new SARS-CoV-2 Heat Inactivated Culture Fluid (0810587CFHI-0.5mL) is available for immediate Research and Assay Development.
ZeptoMetrix® new non-infectious NATtrol SARS-CoV-2 Recombinant (0831042) and NATtrol SARS-CoV-2(E/ORF1ab recombinant)(0831043) - is available to laboratories for test development, validation, and quality control.
ZeptoMetrix® newly inactivated and non-infectious NATtrol™ SARS-CoV-2 Recombinant is available for sale